Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05775562
Other study ID # 29BRC21.0273
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 19, 2023
Est. completion date September 24, 2025

Study information

Verified date October 2023
Source University Hospital, Brest
Contact Erwan L'HER, PhD
Phone +33298347181
Email erwan.lher@chu-brest.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Scuba diving with closed circuit gas rebreathers is currently booming. Initially developed for professional and military diving, this type of diving has become very successful in recreational activities. The possibilities offered by this equipment are immense and reduce the constraints of exploration time and depth. More and more divers are seeking to reach depths previously considered unusual or inaccessible in recreational diving, beyond 100 meters. By pushing back these limits, the diver is exposed to new risks which should lead to a reflection on the means of prevention and treatment in case of incident. The physiological repercussions of these deep dives are not well known. During daily deep excursions in the 90-120 meter zone, there is a significant reduction in vital capacity on leaving the dive, which persists and worsens the following day. It seems necessary to confirm the importance of this impairment, never documented before, and to explore its mechanisms. A better knowledge of this respiratory impact could allow to improve the prevention and the preliminary evaluation of the medical aptitude of these divers.


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date September 24, 2025
Est. primary completion date September 24, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Diver = 18 years old - Recreational rebreather diver with a recognised qualification (Mixed Gas CCR training or equivalent) and the necessary experience for this type of diving who has scheduled a dive in the 60 metre depth zone - Diver using his/her own equipment, i.e. a closed circuit rebreather with back lungs meeting CE standards. - Having a medical certificate of no contraindication to the practice of underwater activities < 1 year issued by an authorised doctor - Having taken out personal insurance covering this type of activity - Voluntary and having given his/her express, free and informed consent - Affiliated to the Social Security Exclusion Criteria: - Diver refusal - Known previous respiratory pathology - Use of medication that may alter pulmonary and/or vascular function as well as inflammatory and haemostasis parameters - Any temporary contraindication to the practice of scuba diving - Patient under guardianship or trusteeship - Immersion beyond 30 metres within 7 days or any scuba diving within the previous 48 hours.

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Pre and post dive examinations
Performing pre-dive examinations: - EFR by plethysmography cabin Realization of the examinations the day of the dive: Portable Spirometry Pulmonary ultrasound Cardiac ultrasound Measurement of circulating bubbles ECG Venous blood sampling (biological collection) Water balance (?weight/water intake) EFR by plethysmography cabin Weight measurement Realization of the examinations the day after the dive: Venous blood sample (biological collection) Portable Spirometry Pulmonary ultrasound Cardiac ultrasound Weight measurement

Locations

Country Name City State
France CHU de BREST Brest

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Brest

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Variation in Vital Capacity Measurement before and after diving Vital capacity measurement will be performed by plethysmography and spirometry (Measurement of mobilizable and non-mobilizable lung volumes (mL)) Day 0 (before diving)
Primary Variation in Vital Capacity Measurement before and after diving Vital capacity measurement will be performed by plethysmography and spirometry (Measurement of mobilizable and non-mobilizable lung volumes (mL)) Day 0 (after diving)
Primary Variation in Vital Capacity Measurement before and after diving Vital capacity measurement will be performed by plethysmography and spirometry (Measurement of mobilizable and non-mobilizable lung volumes (mL)) Day +1
Secondary Variations in Spirometry data before and after diving Measurement of SPO2 (%), CVF (L), VEMS (L), VEMS/CVF (%), DEP (L/S) and DEMM (L/S) before and after diving by spirometry Day -XX before diving
Secondary Variations in Spirometry data before and after diving Measurement of SPO2 (%), CVF (L), VEMS (L), VEMS/CVF (%), DEP (L/S) and DEMM (L/S) before and after diving by spirometry Day 0 (before diving)
Secondary Variations in Spirometry data before and after diving Measurement of SPO2 (%), CVF (L), VEMS (L), VEMS/CVF (%), DEP (L/S) and DEMM (L/S) before and after diving by spirometry Day 0 (after diving)
Secondary Variations in Spirometry data before and after diving Measurement of SPO2 (%), CVF (L), VEMS (L), VEMS/CVF (%), DEP (L/S) and DEMM (L/S) before and after diving by spirometry Day +1
Secondary Variations in plethysmography data before and after diving Measurement of CV max (L), CVF (L), VRE (L), VRI (L), VT (L), VEMS (L), VR (L) and CPT (L) before and after diving by plethysmography Day -XX before Day 0
Secondary Variations in plethysmography data before and after diving Measurement of DEP (L.S), DEM 75 (L/S), DEM 50 (L/s), DEM 25 (L/S) before and after diving by plethysmography Day -XX before Day 0
Secondary Variations in plethysmography data before and after diving Measurement of CV max (L), CVF (L), VRE (L), VRI (L), VT (L), VEMS (L), VR (L) and CPT (L) before and after diving by plethysmography Day 0 (before diving)
Secondary Variations in plethysmography data before and after diving Measurement of DEP (L.S), DEM 75 (L/S), DEM 50 (L/s), DEM 25 (L/S) before and after diving by plethysmography Day 0 (before diving)
Secondary Variations in plethysmography data before and after diving Measurement of CV max (L), CVF (L), VRE (L), VRI (L), VT (L), VEMS (L), VR (L) and CPT (L) before and after diving by plethysmography Day 0 (after diving)
Secondary Variations in plethysmography data before and after diving Measurement of DEP (L.S), DEM 75 (L/S), DEM 50 (L/s), DEM 25 (L/S) before and after diving by plethysmography Day 0 (after diving)
Secondary Variations in plethysmography data before and after diving Measurement of CV max (L), CVF (L), VRE (L), VRI (L), VT (L), VEMS (L), VR (L) and CPT (L) before and after diving by plethysmography Day +1
Secondary Variations in plethysmography data before and after diving Measurement of DEP (L.S), DEM 75 (L/S), DEM 50 (L/s), DEM 25 (L/S) before and after diving by plethysmography Day +1
Secondary Variations in DLCO before and after diving Measurement DLCO (mmol/(min*kPa) before and after diving Day 0 (before diving)
Secondary Variations in DLCO before and after diving Measurement DLCO (mmol/(min*kPa) before and after diving Day 0 (after diving)
Secondary Variations in DLCO before and after diving Measurement DLCO (mmol/(min*kPa) before and after diving Day +1
Secondary Variations in lung ultrasound (B lines) before and after diving A B-line count should be performed, which is defined as vertical artefacts, mobile with breathing, continuous, originating from the pleural line and erasing the other artefacts. These artefacts indicate interstitial damage, the importance of which correlates with their number and a very good correlation with the quantity of extrapulmonary water. Day 0 (before diving)
Secondary Variations in lung ultrasound (B lines) before and after diving A B-line count should be performed, which is defined as vertical artefacts, mobile with breathing, continuous, originating from the pleural line and erasing the other artefacts. These artefacts indicate interstitial damage, the importance of which correlates with their number and a very good correlation with the quantity of extrapulmonary water. Day 0 (after diving)
Secondary Variations in lung ultrasound (B lines) before and after diving A B-line count should be performed, which is defined as vertical artefacts, mobile with breathing, continuous, originating from the pleural line and erasing the other artefacts. These artefacts indicate interstitial damage, the importance of which correlates with their number and a very good correlation with the quantity of extrapulmonary water. Day +1
Secondary Variations in lung ultrasound (condensations) before and after diving Ultrasound signs of condensation or pleural effusions should be observed before and after diving. Day 0 (before diving)
Secondary Variations in lung ultrasound (condensations) before and after diving Ultrasound signs of condensation or pleural effusions should be observed before and after diving. Day 0 (after diving)
Secondary Variations in lung ultrasound (condensations) data before and after diving Ultrasound signs of condensation or pleural effusions should be observed before and after diving. Day +1
Secondary Variations in cardiac ultrasound pulmonary pressure (PAPs) before and after diving Pulmonary arterial pressures are assessed by studying pulmonary artery Doppler flow (Acceleration Time) and right ventricular ejection time (RVET) and calculating the Acceleration/RVET ratio. Day 0 (before diving)
Secondary Variations in cardiac ultrasound pulmonary pressure (PAPs) before and after diving Pulmonary arterial pressures are assessed by studying pulmonary artery Doppler flow (Acceleration Time) and right ventricular ejection time (RVET) and calculating the Acceleration/RVET ratio. Day 0 (after diving)
Secondary Variations in cardiac ultrasound pulmonary pressure (PAPs) before and after diving Pulmonary arterial pressures are assessed by studying pulmonary artery Doppler flow (Acceleration Time) and right ventricular ejection time (RVET) and calculating the Acceleration/RVET ratio. Day +1
Secondary Variations in right ventricle function data before and after diving Right ventricular systolic function is assessed by measuring the tricuspid annulus plane systolic excursion (TAPSE) in TM mode and calculating the LV shortening fraction. Day 0 (before diving)
Secondary Variations in right ventricle function data before and after diving Right ventricular systolic function is assessed by measuring the tricuspid annulus plane systolic excursion (TAPSE) in TM mode and calculating the LV shortening fraction. Day 0 (after diving)
Secondary Variations in right ventricle function data before and after diving Right ventricular systolic function is assessed by measuring the tricuspid annulus plane systolic excursion (TAPSE) in TM mode and calculating the LV shortening fraction. Day +1
Secondary Variations in decompression (circulating bubbles) data before and after diving Detection of circulating bubbles by trans-thoracic ultrasound Day 0 (before diving)
Secondary Variations in decompression (circulating bubbles) data before and after diving Detection of circulating bubbles by trans-thoracic ultrasound Day 0 (after diving)
Secondary Variations in biological markers of coagulation activation before and after diving Measurement from the serum library (venous blood samples) of coagulation factors (TFPI, procoagulant microparticles, Fibrin monomer, PF4, C3a, C5a and platelet count) before and after diving. The analyses remain to be specified according to the results of other ongoing investigations Day 0 (before diving)
Secondary Variations in biological markers of coagulation activation before and after diving Measurement from the serum library (venous blood samples) of coagulation factors (TFPI, procoagulant microparticles, Fibrin monomer, PF4, C3a, C5a and platelet count) before and after diving. The analyses remain to be specified according to the results of other ongoing investigations Day 0 (after diving)
Secondary Variations in biological markers of coagulation activation before and after diving Measurement from the serum library (venous blood samples) of coagulation factors (TFPI, procoagulant microparticles, Fibrin monomer, PF4, C3a, C5a and platelet count) before and after diving. The analyses remain to be specified according to the results of other ongoing investigations Day +1
Secondary Variations in biomarkers of lipid peroxidation before and after diving Measurement from the serum library (venous blood samples) of lipoperoxidation (F2-Isoprostane) before and after the dive. The analyses remain to be specified according to the results of other ongoing investigations. Day 0 (before diving)
Secondary Variations in biomarkers of lipid peroxidation before and after diving Measurement from the serum library (venous blood samples) lipoperoxidation (F2-Isoprostane) before and after the dive. The analyses remain to be specified according to the results of other ongoing investigations. Day 0 (after diving)
Secondary Variations in biomarkers of lipid peroxidation before and after diving Measurement from the serum library (venous blood samples) lipoperoxidation (F2-Isoprostane) before and after the dive. The analyses remain to be specified according to the results of other ongoing investigations. Day +1
Secondary Variations in biomarkers of oxidative stress before and after diving Measurement from the serum library (venous blood samples) of oxidative stress factors before and after the dive. The analyses remain to be specified according to the results of other ongoing investigations. Day 0 (before diving)
Secondary Variations in biomarkers of oxidative stress before and after diving Measurement from the serum library (venous blood samples) of oxidative stress factors before and after the dive. The analyses remain to be specified according to the results of other ongoing investigations. Day 0 (after diving)
Secondary Variations in biomarkers of oxidative stress before and after diving Measurement from the serum library (venous blood samples) of oxidative stress factors (as F2-Isoprostane, 8-isoprostane) before and after the dive. The analyses remain to be specified according to the results of other ongoing investigations. Day +1
Secondary Variations in biological markers of inflammation before and after diving Measurement of inflammation factors (CRP and IL1-ß) from the serum library (venous blood samples) before and after the dive. The analyses remain to be specified according to the results of other ongoing investigations. Day 0 (before diving)
Secondary Variations in biological markers of inflammation before and after diving Measurement of inflammation factors (CRP and IL1-ß) from the serum library (venous blood samples) before and after the dive. The analyses remain to be specified according to the results of other ongoing investigations. Day 0 (after diving)
Secondary Variations in biological markers of inflammation before and after diving Measurement of inflammation factors (CRP and IL1-ß) from the serum library (venous blood samples) before and after the dive. The analyses remain to be specified according to the results of other ongoing investigations. Day +1
Secondary Variations in water balance before and after diving Pre- and post-dive water intakes are quantified but no intake restrictions are requested : Weight measured by electronic scale (in kg) Day 0 (before diving)
Secondary Variations in water balance before and after diving Pre- and post-dive water intakes are quantified but no intake restrictions are requested : Weight measured by electronic scale (in kg) Day 0 (after diving)
Secondary Variations in water balance before and after diving Pre- and post-dive water intakes are quantified but no intake restrictions are requested : Weight measured by electronic scale (in kg) Day +1
See also
  Status Clinical Trial Phase
Terminated NCT02004015 - Assessment Study of the Effect of NMBA on Bowel Peristalsis Phase 4
Recruiting NCT06214286 - Adding Shock Wave Therapy to Kinesio Taping Improves Carpal Tunnel Syndrome in Physical Therapist Females. N/A
Recruiting NCT05859191 - Study of Neonatal IgG Fc Receptor Expression in Natural Killer T Cells Expressing an Invariant T Receptor : Implication in the Pathophysiology of Systemic Lupus
Recruiting NCT04959435 - Understanding the Role of Oral Microbiota in Behçet's Disease (BEHCETBIOT)